The FDA Approves the First Prescription Medication for OSA Patients with Obesity
The FDA has approved the first medication useful in treating adults exhibiting moderate-to-severe OSA with obesity. Eli Lilly and Company announced the US Food and Drug Administration (FDA) approved Zepbound (tirzepatide) as the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. “Too often, OSA is brushed off as…